CVS Health Files 8-K on Operations and Personnel

Ticker: CVS · Form: 8-K · Filed: 2024-10-18T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, operations, personnel

Related Tickers: CVS

TL;DR

CVS filed an 8-K detailing operational results and personnel changes as of Oct 17, 2024.

AI Summary

CVS Health Corporation filed an 8-K on October 18, 2024, reporting on events that occurred on October 17, 2024. The filing covers results of operations, financial condition, departure/election of directors and officers, and includes Regulation FD disclosures and financial statements/exhibits. Specific financial figures or executive changes were not detailed in the provided text.

Why It Matters

This 8-K filing provides updates on CVS Health's operational and financial status, as well as any significant changes in its board or executive team, which are crucial for investors to monitor.

Risk Assessment

Risk Level: low — The filing is a standard 8-K reporting routine corporate events and does not appear to contain immediate negative financial news.

Key Players & Entities

FAQ

What specific results of operations or financial condition changes are being reported by CVS Health?

The provided text indicates that the 8-K covers 'Results of Operations and Financial Condition' but does not specify the details of these results or conditions.

Were there any departures or elections of directors or officers on October 17, 2024?

The filing lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item covered, but the specific individuals or changes are not detailed in the provided text.

Does the 8-K filing include any new compensatory arrangements for officers?

The filing mentions 'Compensatory Arrangements of Certain Officers' as a topic, but no specific details about these arrangements are present in the provided excerpt.

What is the significance of the Regulation FD Disclosure mentioned in the filing?

Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, so this section likely contains information that CVS Health is making public to comply with this regulation.

Are there any exhibits or financial statements attached to this 8-K filing?

Yes, the filing explicitly states 'Financial Statements and Exhibits' as an item covered, indicating that these documents are part of the submission.

From the Filing

0001193125-24-239193.txt : 20241018 0001193125-24-239193.hdr.sgml : 20241018 20241018064601 ACCESSION NUMBER: 0001193125-24-239193 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241017 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241018 DATE AS OF CHANGE: 20241018 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 241378876 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 d837701d8k.htm 8-K 8-K CVS HEALTH Corp false 0000064803 0000064803 2024-10-17 2024-10-17     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 17, 2024       CVS HEALTH CORPORATION (Exact Name of Registrant as Specified in Charter)       Delaware   001-01011   05-0494040 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) One CVS Drive Woonsocket , Rhode Island 02895 (Address of Principal Executive Offices, and Zip Code) (401) 765-1500 Registrant’s Telephone Number, Including Area Code N/A (Former name, former address and former fiscal year, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   CVS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 2.02 Results of Operations and Financial Condition. The information set forth under Item 7.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.02.   Item 5.02. Depar

View on Read The Filing